PRASINEZUMAB

UNII:	P3Z0Z3P1ZI
Formula:
Preferred Substance Name:	PRASINEZUMAB

1960462-19-4
HUMANIZED IGG1, KAPPA ANTI-ALPHA-SYNUCLEIN ANTIBODY
IMMUNOGLOBULIN G1, ANTI-(HUMAN .ALPHA.-SYNUCLEIN) (HUMANIZED CLONE PRX002 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE PRX002 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ALPHA-SYNUCLEIN (NACP))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1X HEAVY CHAIN (1-446) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*04 (88%) (IGHD)-IGHJ4*01) (8.8.9) (1-116) -HOMO SAPIENS IGHG1*03 (117-446)) (219-220')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-220') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-16*01 (81%) IGKJ4*01 (92%))(12.3.9) (1'-113') -HOMO SAPIENS IGKC*01 (114'-220'))DIMER (225-225'':228-228'')-BISDISULFIDE
PRASINEZUMAB [INN]
PRASINEZUMAB [USAN]
PRASINEZUMAB [WHO-DD]
PRX002
PRX-002
RG7935
RG-7935
RO7046015
RO-7046015

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PRASINEZUMAB

Synonyms and Mappings

Resources